129 related articles for article (PubMed ID: 31181219)
21. Added value of IgA antibodies against Zika virus non-structural protein 1 in the diagnosis of acute Zika virus infections.
Warnecke JM; Lattwein E; Saschenbrecker S; Stöcker W; Schlumberger W; Steinhagen K
J Virol Methods; 2019 May; 267():8-15. PubMed ID: 30779938
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the Diasorin Liaison® XL Zika Capture IgM CMIA for Zika virus serological testing.
Sloan A; Safronetz D; Makowski K; Barairo N; Ranadheera C; Dimitrova K; Holloway K; Mendoza E; Wood H; Drebot M; Gretchen A; Kadkhoda K
Diagn Microbiol Infect Dis; 2018 Apr; 90(4):264-266. PubMed ID: 29310948
[TBL] [Abstract][Full Text] [Related]
23. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a new rapid fluorescence immunoassay for the diagnosis of dengue and Zika virus infection.
Zammarchi L; Colao MG; Mantella A; Capobianco T; Mazzarelli G; Ciccone N; Tekle Kiros S; Mantengoli E; Rossolini GM; Bartoloni A
J Clin Virol; 2019 Mar; 112():34-39. PubMed ID: 30738366
[TBL] [Abstract][Full Text] [Related]
25. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence.
van Meer MPA; Mögling R; Klaasse J; Chandler FD; Pas SD; van der Eijk AA; Koopmans MPG; Reusken CBEM; GeurtsvanKessel CH
J Clin Virol; 2017 Jul; 92():25-31. PubMed ID: 28505571
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a new commercial enzyme immunoassay for the detection of IgM antibodies to West Nile virus using a ratio method to eliminate nonspecific reactivity.
Welch RJ; Anderson BL; Litwin CM
J Clin Lab Anal; 2008; 22(5):362-6. PubMed ID: 18803272
[TBL] [Abstract][Full Text] [Related]
27. Enzyme-linked immunosorbent assays using virus-like particles containing mutations of conserved residues on envelope protein can distinguish three flavivirus infections.
Tsai WY; Driesse K; Tsai JJ; Hsieh SC; Sznajder Granat R; Jenkins O; Chang GJ; Wang WK
Emerg Microbes Infect; 2020 Dec; 9(1):1722-1732. PubMed ID: 32684139
[TBL] [Abstract][Full Text] [Related]
28. A Systematic Evaluation of IgM and IgG Antibody Assay Accuracy in Diagnosing Acute Zika Virus Infection in Brazil: Lessons Relevant to Emerging Infections.
Medialdea-Carrera R; Levy F; Castanha P; Carvalho de Sequeira P; Brasil P; Lewis-Ximenez LL; Turtle L; Solomon T; Bispo de Filippis AM; Brown DW; Griffiths MJ
J Clin Microbiol; 2021 Nov; 59(12):e0289320. PubMed ID: 34550810
[TBL] [Abstract][Full Text] [Related]
29. Challenges in diagnosing Zika-experiences from a reference laboratory in a non-endemic setting.
Van den Bossche D; Michiels J; Cnops L; Foque N; Meersman K; Huits R; Ariën KK; Van Esbroeck M
Eur J Clin Microbiol Infect Dis; 2019 Apr; 38(4):771-778. PubMed ID: 30680570
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of two commercially available chikungunya virus IgM enzyme-linked immunoassays (ELISA) in a setting of concomitant transmission of chikungunya, dengue and Zika viruses.
Kikuti M; Tauro LB; Moreira PSS; Nascimento LCJ; Portilho MM; Soares GC; Weaver SC; Reis MG; Kitron U; Ribeiro GS
Int J Infect Dis; 2020 Feb; 91():38-43. PubMed ID: 31704226
[TBL] [Abstract][Full Text] [Related]
31. Immunoglobulin-like Domain of
Rackow A; Ehmen C; von Possel R; Medialdea-Carrera R; Brown D; Bispo de Filippis AM; Carvalho de Sequeira P; Ribeiro Nogueira RM; Halili B; Jakupi X; Berisha L; Ahmeti S; Sherifi K; Schmidt-Chanasit J; Schmitz H; Mika A; Emmerich P; Deschermeier C
Clin Chem; 2019 Mar; 65(3):451-461. PubMed ID: 30709812
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance of anti-Zika virus IgM, IgAM and IgG ELISAs during co-circulation of Zika, dengue, and chikungunya viruses in Brazil and Venezuela.
Morales I; Rosenberger KD; Magalhaes T; Morais CNL; Braga C; Marques ETA; Calvet GA; Damasceno L; Brasil P; Bispo de Filippis AM; Tami A; Bethencourt S; Alvarez M; Martínez PA; Guzman MG; Souza Benevides B; Caprara A; Quyen NTH; Simmons CP; Wills B; de Lamballerie X; Drexler JF; Jaenisch T;
PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009336. PubMed ID: 33872309
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Six Commercial Diagnostic Tests for the Detection of Dengue Virus Non-Structural-1 Antigen and IgM/IgG Antibodies.
Lee H; Ryu JH; Park HS; Park KH; Bae H; Yun S; Choi AR; Cho SY; Park C; Lee DG; Lim J; Lee J; Lee S; Shin S; Park H; Oh EJ
Ann Lab Med; 2019 Nov; 39(6):566-571. PubMed ID: 31240885
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a new commercially available immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of dengue virus infection.
Namekar M; Ellis EM; O'Connell M; Elm J; Gurary A; Park SY; Imrie A; Nerurkar VR
J Clin Microbiol; 2013 Sep; 51(9):3102-6. PubMed ID: 23824771
[TBL] [Abstract][Full Text] [Related]
35. Comparison of a commercial dengue IgM capture ELISA with dengue antigen focus reduction microneutralization test and the Centers for Disease Control dengue IgM capture-ELISA.
Welch RJ; Chang GJ; Litwin CM
J Virol Methods; 2014 Jan; 195():247-9. PubMed ID: 24161816
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Commercially Available Chikungunya Virus Immunoglobulin M Detection Assays.
Johnson BW; Goodman CH; Holloway K; de Salazar PM; Valadere AM; Drebot MA
Am J Trop Med Hyg; 2016 Jul; 95(1):182-192. PubMed ID: 26976887
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based survey.
Nguyen CT; Moi ML; Le TQM; Nguyen TTT; Vu TBH; Nguyen HT; Pham TTH; Le THT; Nguyen LMH; Phu Ly MH; Ng CFS; Takemura T; Morita K; Hasebe F
BMC Infect Dis; 2020 May; 20(1):332. PubMed ID: 32393198
[TBL] [Abstract][Full Text] [Related]
38. Harmonization of Zika serological assays and comparative evaluation of two commercial ZIKA IgG ELISA kits.
Sapkal G; Deshpande GR; Gupta N; Deshpande K; Sharma S; Tandale B; Srivastava R; Vidhate S; Khutwad K; Tilekar BN
Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116238. PubMed ID: 38554539
[TBL] [Abstract][Full Text] [Related]
39. Use of the immunoglobulin G avidity assay to differentiate between recent Zika and past dengue virus infections.
Furuya AKM; Hunt D; George KS; Dupuis AP; Kramer LD; Shi PY; Wong S
Clin Sci (Lond); 2019 Apr; 133(7):859-867. PubMed ID: 30902827
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of 5 Commercially Available Zika Virus Immunoassays.
Safronetz D; Sloan A; Stein DR; Mendoza E; Barairo N; Ranadheera C; Scharikow L; Holloway K; Robinson A; Traykova-Andonova M; Makowski K; Dimitrova K; Giles E; Hiebert J; Mogk R; Beddome S; Drebot M
Emerg Infect Dis; 2017 Sep; 23(9):1577-1580. PubMed ID: 28665268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
